The Innovation Fund


Innovative application of probiotic technology to improve existing baby and young children cereals for the prevention of diarrhoea

 

Agricultural Research Council (ARC) - Animal Nutrition and Products Institute

Proposal number:

32113

Focal area:

Value-adding

Project duration:

3 years

Total funding:

R 3,644,000

Funding year 1:

R 915,000

Funding year 2:

R 1,400,000

Funding year 3:

R 1,329,000

Diarrhoeal diseases are the leading cause of death among children under the age of five in South Africa, accounting for approximately 40% of deaths in this group. Globally over 3 million deaths are reported resulting from diarrhoea of which 80% are children below 5 years of age.

Diarrhoea can be caused by viruses, bacteria or by a mixed infection. Rotavirus (not treatable with antibiotics) is the main causative viral agent among children and a number of bacteria (Salmonella, Shigella, Escherichia coli, etc.) have been associated with forms of gastroenteritis. Both, the antibiotic treatment and rehydration are expensive and frequently require hospitalization.

Certain naturally occurring intestinal bacteria protect humans from intestinal infections. However, they are depleted during periods of malnutrition, antibiotic treatment, stress or when an infant has compromised immunity. With the natural protective bacteria depleted intestinal infections occur readily of which the most common symptom is diarrhoea. These protective intestinal bacteria have been isolated from healthy infants and can be cultivated in the laboratory to be re-introduced in sufficient numbers into the intestinal tract of infants and young children.

Existing baby and young children breakfast cereals can be fortified with these health-promoting bacteria, probiotics. However, the bacteria need to be refrigerated to sustain their viability. Product development is needed to maintain the probiotics' viability at room temperature, in order to include them into the existing infant formulas and baby cereals. Various ways of incorporating the probiotics into the foods or other methods of administration will be investigated, such as micro-encapsulation of the bacteria into a chemical matrix or packaging materials that would protect the bacteria. The introduction of these life saving products would introduce to South Africa new technologies that will improve the quality of the lives of the children of South Africa, especially that of infants.

Project Coordinator:

Dr CH Horn
Phone: +27 (0)12 672 9022
email: chorn@idpi1.agric.za

 

Public reports / Newsletters: 

  • none 

 

 | Back to projects table | Top of page | 

 

Home

Introduction

Most recent call

Applications

Projects funded

Management

Collaborators

Other Funds

F A Q

Contact us

Online Services

Copyright © 2001, Innovation Fund Trust. This web site was developed by the Science & Technology web administrator.
Last updated: 29 November 2001 .   Disclaimer